Registration - coming soon
Day 1: Thursday, October 17, 2024
8:00-8:05 Welcome from the CMCR Director, Igor Grant, MD
2024 CMCR Symposium Awards
8:05-8:40 Alexandros Makriyannis, PhD - CMCR Pioneer in Medicinal Cannabis Research Award
Presentation of Award and Keynote Address
This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.
8:40-9:15 Mark Ware, MD, MRCP(UK), MSc - CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics
Presentation of Award and Keynote Address
This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.
9:15-9:55 Moderated panel discussion and Q&A with 2024 CMCR Symposium Award Recipients & previous award recipients
2023 Award Recipients: Marilyn Huestis, PhD and Margaret (Meg) Haney, PhD
2022 Award Recipients: Daniele Piomelli, PhD and Donald Abrams, MD
2019 Award Recipients: Geoffrey Guy, MD
9:55-10:00 5-minute break
CMCR Special Lectures
10:00-10:20 Nathaniel Schuster, MD - A randomized clinical trial of cannabis for migraine headaches
10:20-10:30 Q&A with Mark Wallace, MD (Dr. Schuster's collaborator) moderated by J. Hampton Atkinson, MD
10:30-10:50 Veena Ranganath, MD, MS - A randomized clinical trial of cannabidiol to reduce joint inflammation in rheumatoid arthritis
10:50-11:00 Q&A moderated by J. Hampton Atkinson, MD
Healthy Aging
11:00-11:15 Alison Moore, MD, MPH, FACP - A perspective on cannabis and healthy aging
11:15-11:30 Kim Finley, PhD - Impact of cannabinoids on Drosophila longevity and traumatic injury response
11:30-11:45 Michael Petracheck, PhD - Induction of C. elegans longevity by endocannabinoid modulators
11:45-11:55 Moderated panel discussion with the speakers and Q&A
12:00-1:00 Poster Session
Day 2: Friday, October 18, 2024
Dementia
8:00-8:15 Pamela Maher, PhD - Efficacy of cannabinoids in a pre-clinical drug-screening platform for Alzheimer's Disease
8:15-8:30 Krista L. Lanctot, PhD - Randomized clinical trial of nabilone for the treatment of agitation in dementia
8:30-8:45 Brent Forester, MD, MSc - Randomized clinical trial of dronabinol for the treatment of agitation in dementia
8:45-8:55 Moderated panel discussion with the speakers and Q&A
8:55-9:00 5-minute break
Cancer Treatment
9:00-9:15 Nephi Stella, PhD - Anti-tumor activity of cannabinoid-based molecules
9:15-9:30 Chris Twelves, PhD - Nabiximols with temozolomide in patients with recurrent glioblastoma
9:30-9:45 Joseph A. Califano, MD - Diverse effects of cannabinoids on head and neck squamous cell carcinoma
9:45-9:55 Moderated panel discussion with the speakers and Q&A
9:55-10:00 5-minute break
Use of cannabis and cannabinoids among older adults and people with cancer
10:00-10:15 Ilana Braun, MD - Cannabis and cannabinoids in adults with cancer
10:00-10:15 Patricia Di Ciano, PhD - Cannabis and driving in older adults
10:00-10:15 Linda Hill, MD, MPH - Impact of recreational cannabis use legalization on older adults in California
10:45-10:55 Moderated panel discussion with the speakers and Q&A
10:55-11:00 5-minute break
NIH Institute Panel
11:00-11:55 Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR
The invited Federal stakeholders will discuss future directions in funding for medicinal cannabis and new directions in aging and cancer care featuring the following panelists:
Alexis Bakos, PhD, MPH, RN, Program Director, Division of Geriatrics and Clinical Gerontology, National Institute on Aging
Andrew Freedman, PhD, Chief, Epidemiology and Genomics Research Program, Clinical and Translational Epidemiology Branch, National Cancer Institute
David Shurtleff, PhD, National Center on Complementary and Integrative Health (NCCIH)
Susan Weiss, PhD, Director, Division of Extramural Research, National Institute on Drug Abuse
11:55-12:00 Closing Remarks from the CMCR Director, Igor Grant, MD
2024 Speaker Bios - coming soon
2024 CMCR Symposium Sponsors - coming soon